East Brunswick, NJ, United States of America

Sanyasi Raju Kalidindi

This inventor holds 22 USPTO granted patents and 21 published patent applications, plus 3 CIPO patents and 4 EPO patents, primarily in Pharmaceutical Compositions. Top assignees: Natreon, Inc., Burroughs Wellcome Co., Glaxo Wellcome Inc.. Active years: 1994-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sanyasi Raju Kalidindi. Retrieved from https://idiyas.com/inventor/sanyasi-raju-kalidindi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 22 

% Patents Active = 95.5

 

 

Average Co-Inventor Count = 1.2

ph-index = 9

Forward Citations = 425(Granted Patents)


Location History:

  • Edison, NJ (US) (1994 - 1998)
  • New Brunswick, NJ (US) (1998)
  • East Brunswick, NJ (US) (1998 - 2015)
  • Monroe, NJ (US) (2017 - 2021)

Company Filing History:


Years Active: 1994-2021

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Pharmaceutical Composition
Cardiovascular Health
Blood Microperfusion
Osteoarthritis Treatment
Personal Care Formulations
Powder Sampling
Indolealkylamino Conjugates
Endothelial Function
Bupropion Hydrochloride
Flexible Swabbing Tool
Blended Powder Samples
Liquid Sampler
22 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Sanyasi Raju Kalidindi

Introduction

Sanyasi Raju Kalidindi, based in East Brunswick, NJ, is an accomplished inventor with an impressive portfolio of 22 patents. His work primarily focuses on innovative solutions in health and wellness, particularly through the utilization of natural extracts and compounds.

Latest Patents

Among his latest inventions, Kalidindi has developed a method for blood microperfusion to the skin using Shilajit. This innovation presents methods for employing Shilajit or its components to improve skin microperfusion and enhance the expression of extracellular matrix (ECM) related genes, thus promoting overall skin health. Another notable patent involves the use of Terminalia chebula extract for the treatment of osteoarthritis. This patent specifies an enriched hydrolyzable tannoid blend which has been formulated to provide effective pain relief and reduce inflammation in individuals suffering from this condition.

Career Highlights

Throughout his career, Sanyasi Raju Kalidindi has contributed significantly to the field through his inventions and has worked with Natreon, Inc., among other organizations. His innovative approach and dedication have established him as a notable inventor in the realm of natural health solutions.

Collaborations

Kalidindi has collaborated with prominent professionals in his field, including Shibnath Ghosal and Muruganandam Veeraragavan. These partnerships have fostered a collaborative environment for research and development, leading to successful patent filings and contributions to scientific knowledge.

Conclusion

Sanyasi Raju Kalidindi exemplifies how innovative thinking combined with practical applications can lead to significant advancements in health and wellness. His dedication to improving skin health and treating conditions like osteoarthritis through natural extracts highlights the importance of research and patents in driving progress in the biomedical field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…